This article was originally published in The Gray Sheet
Plans to submit an investigational device exemption application to FDA "in late 1993" for clinical trials of "a new advanced family of laser catheters" that will "more effectively vaporize" arterial plaque, according to a July 19 release. The laser catheters are designed "to create a channel significantly larger than their diameter and restore normal blood flow, without the need to follow the laser procedure with balloon angioplasty," the firm says. Trimedyne recently acquired a patent covering the catheter technology from Robert Ginsburg, MD, University of Colorado; terms were not disclosed.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.